Medicine and Dentistry
Ganglioglioma
100%
Circulating Tumor Cell
85%
Ependymoma
85%
Xenograft
85%
Epileptic Seizure
85%
Closed Head Injury
85%
Drug Screening
85%
Metastatic Carcinoma
85%
Electroencephalogram
85%
Neoplasm
79%
Lorlatinib
34%
Central Nervous System
34%
Surgery
31%
Radiation Therapy
31%
Liquid Biopsy
28%
Therapeutic Agent
28%
Everolimus
28%
Glasgow Coma Scale
19%
Partial Seizure
19%
Etoposide
17%
Spindle Cell Carcinoma
17%
Brain Tumor
17%
Carboplatin
17%
Gestational Age
17%
Pediatric Brain Tumor
17%
Growth, Development and Aging
17%
Congenital Hydrocephalus
17%
Cyclophosphamide
17%
ALK Inhibitor
17%
Tyrosine-Kinase Inhibitor
17%
RNA Sequence
17%
Thalamus
17%
Targeted Therapy
17%
Tumor Biopsy
17%
Horn
17%
Fusion Gene
17%
Basal Ganglia
17%
Magnetic Resonance Imaging
17%
Ventricle of Heart
17%
Tumor Cell
14%
Cell Viability
14%
Entrectinib
14%
Salvage Therapy
14%
Bone Scintigraphy
14%
Personalized Medicine
14%
Cell Screening
14%
Therapeutic Modality
14%
Tumor Recurrence
14%
Adjuvant Chemotherapy
14%
Tumor Progression
14%
Biochemistry, Genetics and Molecular Biology
Thiosulfate
85%
Prevalence
85%
Promoter Region
85%
Macrophage
85%
B Cell
85%
E2F1
85%
Cell Cycle
85%
Reductase
85%
Oxidoreductase
85%
RELA
42%
DNA Methylation
42%
RNA Sequence
42%
DNA Damage
36%
Overall Survival
29%
Immunocompetent Cell
28%
Cytokine
28%
Mast Cell
28%
Sonic Hedgehog
28%
Cell Cycle Checkpoint
24%
Cell Cycle Arrest
24%
Programmed Cell Death
24%
Population
21%
CXCL13
14%
CCL27
14%
Recurrence Free Survival
14%
Cell Composition
14%
Transcriptome
14%
S Phase
12%
Real-Time Polymerase Chain Reaction
12%
Western Blot
12%
Recombination Repair
12%
Flow Cytometry
12%
Tumor Progression
12%
Homologous Recombination
12%
G1 Phase
12%
DNA Repair
12%
Ribonucleotide Reductase
12%
Upregulation
7%
Epigenetics
7%
Methylation
7%
Transfection
7%
Epirubicin
7%
Small Interfering RNA
7%
Pharmacology, Toxicology and Pharmaceutical Science
Ependymoma
85%
Atypical Teratoid Rhabdoid Tumor
85%
Abemaciclib
85%
Oxidoreductase
85%
Western Blot
28%
Survival Rate
28%
Side Effect
14%
Mouse Model
14%
Tumor Growth
14%
Ribonucleotide Reductase
14%
Intracranial Tumor
14%
Drug Resistance
14%
Radiation Exposure
14%
Chemoradiation Therapy
14%
Progression Free Survival
14%
Brain Cancer
14%
Neoplasm
14%
Flow Cytometry
14%
Recurrent Disease
14%